FR 182024

structure in first source

Also Known As:

FR-182024; FR182024

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Diarrhea 11/01/1999 - "FR182024 having a (5-methyl-1,3,4-thiadiazol-2-yl)-thio moiety at the 3-position and a phenylacetamido at the 7-position was found to have extremely potent in vitro anti-H.pylori activity, superior therapeutic efficacy to AMPC and CAM, and low potential for causing diarrhea."